Table 1.
AlloHSCT survivors' sociodemographic and disease related characteristics.
| Characteristics | Survivors | |
|---|---|---|
| N | 32 | In % |
| Gender | ||
| Female | 16 | 50% |
| Male | 16 | 50% |
| Nationality | ||
| German | 31 | 97% |
| Others | 1 | 3% |
| Median Age in years (SD) | 48.0 | 14.1 |
| 18–39 y | 11 | 34% |
| 40–59 y | 11 | 34% |
| 60+ y | 10 | 31% |
| Material status | ||
| Married | 21 | 66% |
| Stable Relationship | 4 | 13% |
| Single/widowed | 7 | 22% |
| Highest level of education | ||
| No university degree* | 22 | 69% |
| University degree | 10 | 31% |
| Occupation | ||
| Full-time | 6 | 19% |
| Part-time | 9 | 28% |
| None/pension | 15 | 47% |
| Children | ||
| Non-Adult Children | 12 | 38% |
| Adult Children | 8 | 25% |
| None | 12 | 38% |
| Median Time post HSCT in years (SD) | 2.5 | 1.1 |
| 1–2 y | 8 | 25% |
| 2–3 y | 15 | 47 % |
| 3–4 y | 3 | 9% |
| 4–5 y | 6 | 19% |
| Diseases | ||
| Acute myeloid leukemia | 9 | 28% |
| Acute lymphoblastic leukemia | 7 | 22% |
| Non-Hodgkin Lymphoma | 5 | 16% |
| Chronic myeloid leukemia | 3 | 9% |
| Lymphoma | 2 | 6% |
| Myeloproliferative disease | 2 | 6% |
| Inborn immunodeficiency | 2 | 6% |
| Others | 2 | 6% |
| cGvHD at time of interview (clinician reported) | ||
| None | 10 | 31% |
| Mild | 2 | 6% |
| Moderate | 9 | 28% |
| Severe | 11 | 34% |
*
Year 10 or lower, A levels.